DA
BCAB icon

Denali Advisors’s BioAtla BCAB Stock Holding History

Denali Advisors’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-146
Closed -$21.9K – 475
2023
Q2 		$21.9K Hold
146
– – 0.01% 335
2023
Q1 		$19.6K Hold
146
– – 0.01% 298
2022
Q4 		$60.2K Hold
146
– – 0.03% 205
2022
Q3 		$56K Buy
+146
New +$47.8K 0.03% 200

Other funds holding BCAB

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Denali Advisors's BCAB Position: Q3 2023 in Review

Denali Advisors sold out of BioAtla (BCAB) in Q3 2023, closing a stake of 146 shares — an estimated $21.9K sold.

Denali Advisors first reported a position in BCAB in Q3 2022 and held it in 4 quarters. The position peaked at $60.2K in Q4 2022. 82 funds tracked by Wall St. Rank hold BCAB as of Q3 2023.

  • Denali Advisors reported no remaining BioAtla position as of Q3 2023 after selling out during the quarter.
  • Denali Advisors sold 146 BioAtla shares in Q3 2023, an estimated $21.9K.
  • Denali Advisors first reported a position in BioAtla in Q3 2022 and held it in 4 quarters.
  • Denali Advisors's BioAtla position peaked at $60.2K in Q4 2022.
  • 82 funds tracked by Wall St. Rank held BioAtla as of Q3 2023.

Based on Denali Advisors's 13F filing for Q3 2023, filed 19 Oct 2023.